Upgrade to SI Premium - Free Trial

Entera Bio Ltd. (ENTX)

3.05 +0.03 (0.99%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form DEF 14A Entera Bio Ltd. For: Oct 14 October 14, 2026 4:05 PM - SEC Filing Entera Bio shares Phase 2 data and Phase 3 design for oral PTH tablet October 13, 2026 7:01 AM - StreetInsider Entera Bio shares Phase 2 EB613 bone density data at ASBMR meeting October 13, 2026 7:01 AM - StreetInsider Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at AS October 13, 2026 7:00 AM - Globe NewsWire Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at AS October 13, 2026 7:00 AM - StreetInsider Entera Bio to present EB613 Phase 3 study design at ASBMR meeting October 8, 2026 8:00 AM - StreetInsider Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting October 8, 2026 8:00 AM - StreetInsider Entera Bio adds former Gilead executive Laura Hamill to its board October 6, 2026 8:00 AM - StreetInsider Form 8-K Entera Bio Ltd. For: Oct 06 October 6, 2026 8:00 AM - SEC Filing Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise October 6, 2026 8:00 AM - StreetInsider Guggenheim Starts Entera Bio (ENTX) at Buy September 25, 2026 3:15 AM - StreetInsider Form PRE 14A Entera Bio Ltd. For: Sep 23 September 23, 2026 4:06 PM - SEC Filing Cantor Fitzgerald Starts Entera Bio (ENTX) at Overweight September 22, 2026 6:13 AM - StreetInsider Leerink Starts Entera Bio (ENTX) at Outperform September 18, 2026 7:00 AM - StreetInsider Form 424B3 Entera Bio Ltd. August 28, 2026 4:14 PM - SEC Filing Correction: Entera to Participate in Upcoming Fall Investor Conferences August 27, 2026 9:44 AM - Globe NewsWire Entera to Participate in Upcoming Fall Investor Conferences August 27, 2026 8:00 AM - StreetInsider Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders August 21, 2026 4:19 PM - StreetInsider Form S-3 Entera Bio Ltd. August 21, 2026 4:16 PM - SEC Filing Form 3 Entera Bio Ltd. For: Aug 18 Filed by: Camisasca Riccardo Paolo August 21, 2026 7:34 AM - SEC Filing Form 8-K Entera Bio Ltd. For: Aug 18 August 18, 2026 8:01 AM - SEC Filing Entera Bio names Riccardo Camisasca as chief medical officer August 18, 2026 8:00 AM - StreetInsider Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation August 18, 2026 8:00 AM - StreetInsider Form D Entera Bio Ltd. August 12, 2026 11:22 AM - SEC Filing Entera Bio Ltd. (ENTX) Misses Q2 EPS by 5c August 10, 2026 5:59 AM - StreetInsider Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Rubin Steven D August 7, 2026 4:23 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Malca Yonatan August 7, 2026 4:23 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Taitel Haya August 7, 2026 4:22 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Ellis Sean August 7, 2026 4:21 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Yaacov-Garbeli Dana August 7, 2026 4:21 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Burshtein Gregory August 7, 2026 4:21 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Galitzer Hillel August 7, 2026 4:21 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Toledano Miranda Jayne August 7, 2026 4:20 PM - SEC Filing Form 4 Entera Bio Ltd. For: Aug 07 Filed by: Germano Geno J August 7, 2026 4:20 PM - SEC Filing Form S-8 Entera Bio Ltd. August 7, 2026 4:13 PM - SEC Filing Form 10-Q Entera Bio Ltd. For: Jun 30 August 7, 2026 4:11 PM - SEC Filing Form 8-K Entera Bio Ltd. For: Aug 07 August 7, 2026 4:07 PM - SEC Filing Entera Announces Second Quarter 2026 Financial Results and Business Updates August 7, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G Entera Bio Ltd. Filed by: Longitude Capital Partners V, LLC August 4, 2026 8:18 PM - SEC Filing Form SCHEDULE 13G Entera Bio Ltd. Filed by: Seven Fleet Capital Management LP August 4, 2026 7:10 PM - SEC Filing Form SCHEDULE 13D Entera Bio Ltd. Filed by: BIOTECHNOLOGY VALUE FUND L P August 4, 2026 7:07 PM - SEC Filing Form SCHEDULE 13G Entera Bio Ltd. Filed by: TCG Crossover GP III, LLC August 4, 2026 4:25 PM - SEC Filing Form SCHEDULE 13G Entera Bio Ltd. Filed by: Vivo Opportunity Fund Holdings, L.P. August 4, 2026 2:49 PM - SEC Filing Entera Bio EB613 phase 2 data selected for ASBMR 2026 plenary August 4, 2026 8:30 AM - StreetInsider Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at th August 4, 2026 8:30 AM - StreetInsider Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference July 31, 2026 4:30 PM - StreetInsider Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE July 29, 2026 3:00 PM - PR NewsWire Form 8-K Entera Bio Ltd. For: Jul 26 July 28, 2026 4:13 PM - SEC Filing Entera Bio prices $275M private placement led by BVF Partners July 27, 2026 8:30 AM - StreetInsider Entera Bio prices $275 million private placement led by BVF Partners July 27, 2026 8:30 AM - StreetInsider Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement July 27, 2026 8:30 AM - Globe NewsWire Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement July 27, 2026 8:30 AM - StreetInsider Full Article List